Papillary Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Papillary Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer [Phase 2]
Phase 2 clinical trial evaluating the combination of Bevacizumab, Erlotinib, and Atezolizumab for advanced renal cell carcinoma. The study i…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Addition of a New Anti-cancer Drug, Radium-223 Dichloride, to the Usual Treatment (Cabozantinib) for Advanced Renal Cell Cancer That Has Spread to the Bone, RadiCaL Study [Phase 2]
Phase 2 trial exploring the addition of radium-223 dichloride to cabozantinib for advanced renal cell carcinoma with bone metastases (RadiCa…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing Cabozantinib With or Without Atezolizumab in Patients With Advanced Papillary Kidney Cancer, PAPMET2 Trial [Phase 2]
Phase 2 PAPMET2 trial evaluates cabozantinib with or without atezolizumab in patients with advanced papillary renal cell carcinoma, includin…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Palbociclib and Sasanlimab for the Treatment of Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Papillary Renal Cell Carcinoma (pRCC) [Phase 1, Phase 2]
A sponsor-backed Phase 1/2 clinical trial evaluates the combination of palbociclib and sasanlimab for advanced clear cell renal cell carcino…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: CBM588 in Combination With Nivolumab and Cabozantinib for the Treatment of Advanced or Metastatic Kidney Cancer [Phase 1]
Phase 1 trial evaluating CBM588 in combination with nivolumab and cabozantinib for advanced or metastatic renal cell carcinoma.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Tumor-Derived Extracellular Vesicles for Noninvasive Molecular Classification of Kidney Cancer
A Mayo Clinic-led clinical trial is evaluating whether tumor-derived extracellular vesicles can noninvasively classify different kidney canc…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Biopsy [NA]
This is an update on a clinical research study (NCT04623502) investigating kidney and urothelial tumor metabolism in patients undergoing sur…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Cabozantinib In Combo With NIVO + IPI In Advanced NCCRCC [Phase 2]
Phase 2 clinical trial update evaluating cabozantinib in combination with nivolumab and ipilimumab for advanced non-clear cell renal cell ca…
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: Cabozantinib or Sunitinib Malate in Treating Participants With Metastatic Variant Histology Renal Cell Carcinoma [Phase 2]
Phase 2 clinical trial evaluating cabozantinib or sunitinib malate in patients with metastatic variant histology renal cell carcinoma, inclu…
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Identification of Novel High Quality Methylated DNA Markers in Renal Tumors: Whole Methylome Discovery, Tissue Validation, and Feasibility Testing In Blood and Urine, The INQUIRE Study
A Mayo Clinic-led INQUIRE study is identifying novel high-quality methylated DNA markers for renal tumors. The project uses whole-methylome …
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Real World Study of Effectiveness of Sunitinib or Sorafenib to Chinese Unresectable Locally Advanced or Metastatic PRCC
A real-world study in China evaluating the effectiveness of sunitinib or sorafenib for unresectable, locally advanced or metastatic papillar…
-
CLINICAL_TRIALS research · 2025-05-08Clinical Trial Update: Savolitinib Plus Durvalumab Versus Sunitinib and Durvalumab Monotherapy in MET-Driven, Unresectable and Locally Advanced or Metastatic PRCC [Phase 3]
Phase 3 trial comparing Savolitinib plus Durvalumab versus Sunitinib and Durvalumab monotherapy in MET-driven papillary renal cell carcinoma…
-
CLINICAL_TRIALS research · 2025-03-25Clinical Trial Update: Study of Kidney Tumors in Younger Patients
The Children's Oncology Group study of kidney tumors in younger patients is currently active but not recruiting. It covers multiple pediatri…